Form 4: USANA Director Sells Shares in Pre-Planned Transaction
Insider Transaction Report
USANA Health Sciences Director Frederic J. Winssinger sold 2,000 shares of common stock for $19.21 per share in a pre-planned transaction.
Summary
- Director Frederic J. Winssinger of USANA Health Sciences Inc. (USNA) reported a sale of common stock.
- The transaction involved the disposition of 2,000 shares of common stock.
- The shares were sold at a price of $19.21 per share.
- The transaction date was 11/10/2025.
- Following this transaction, Mr. Winssinger directly owns 5,986 shares of USANA common stock.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it was pre-arranged.
Sentiment
Score: 4
Explanation: The sale of shares by a director, even if pre-planned under Rule 10b5-1, is generally viewed with slight negative sentiment as it reduces insider ownership. However, the pre-planned nature significantly mitigates the immediate negative implications, making it an expected event under the established plan.
Negatives
- A director, Frederic J. Winssinger, sold 2,000 shares of common stock, reducing his direct beneficial ownership.
- While pre-planned, insider selling can sometimes be interpreted by the market as a reduction in an insider's direct stake in the company.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders may interpret the director's sale as a signal regarding the company's future prospects or the director's personal financial planning, though the Rule 10b5-1 plan suggests a pre-determined action.
Key Dates
| Date | Description |
|---|---|
| 11/10/2025 | Date of common stock transaction (sale) by Director Frederic J. Winssinger. |
Recommendation
holdThe director's sale of 2,000 shares, while a reduction in insider ownership, was conducted under a Rule 10b5-1 plan. This indicates the transaction was pre-scheduled and not necessarily a reaction to new, negative information. This mitigates the immediate negative signal. Investors should monitor future insider activity and broader company performance rather than reacting solely to this single, pre-planned transaction, thus a 'hold' recommendation is appropriate.
Keywords
USANA Health Sciences, USNA, Insider Trading, Form 4, Director Stock Sale, Frederic J Winssinger, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.